Tag: Lee Rubin

  • Health

    How old can we get? It might be written in stem cells

    No clock, no crystal ball, but lots of excitement — and ambition — among Harvard scientists

    9–13 minutes
  • Health

    Compound protects nerve cells targeted by diseases

    Harvard researchers have identified a compound that helps protect the cells destroyed by spinal muscular atrophy, the most frequent fatal genetic disease of young children.

    4–5 minutes
  • Health

    Hope against disease targeting children

    Harvard Stem Cell Institute researchers studying spinal muscular atrophy have found molecular changes that help trigger the genetic disease in children.

    3–5 minutes
  • Health

    Vital genes in fat production found

    Scientists at Harvard Stem Cell Institute have found a way to both make more energy-burning human brown fat cells and make the cells themselves more active, a discovery that could have therapeutic potential for diabetes, obesity, and other metabolic diseases.

    2–3 minutes
  • Health

    Creating pain-sensing neurons

    Harvard Stem Cell Institute researchers at Boston Children’s Hospital and Harvard’s Department of Stem Cell and Regenerative Biology have successfully converted mouse and human skin cells into pain-sensing neurons that respond to a number of stimuli that cause acute and inflammatory distress.

    3–5 minutes
  • Health

    A decade of breakthroughs

    The Harvard Stem Cell Institute is now 10 years old. What began as an idea embracing cross-disciplinary research quickly became a generator of scientific discoveries.

    3–5 minutes
  • Health

    Hope for aging brains, skeletal muscle

    Researchers at the Harvard Stem Cell Institute have shown that a protein, one they previously demonstrated can make failing hearts in aging mice appear more like those of young and healthy mice, similarly improves brain and skeletal muscle function in aging mice.

    6–8 minutes
  • Health

    Developing cancer drugs

    Harvard Stem Cell Institute researchers have identified in the most aggressive forms of cancer a gene known to regulate embryonic stem cell self-renewal, beginning a creative search for a drug that can block its activity.

    3–5 minutes
  • Health

    Big boost in drug discovery

    Using a new, stem cell-based, drug-screening technology that could reinvent and greatly reduce the cost of developing pharmaceuticals, researchers at the Harvard Stem Cell Institute have found a compound that is more effective in protecting the neurons killed in amyotrophic lateral sclerosis than are two drugs that failed in human clinical trials.

    4–6 minutes
  • Health

    Personalized medicine closer to reality

    A consortium of scientists at 20 institutions, led by a principal faculty member at the Harvard Stem Cell Institute, has used stem cells to take a major step toward developing personalized medicine to treat Parkinson’s disease.

    2–4 minutes
  • Campus & Community

    Learning about research

    Nearly 150 Harvard undergraduates spent 10 weeks last summer learning the nuts and bolts of academic research — from ethnography to techniques for culturing living tissue — with faculty in three immersive programs.

    6–9 minutes
  • Health

    Harvard team reports major step forward in cell reprogramming

    A team of Harvard Stem Cell Institute (HSCI) researchers has made a major advance toward producing induced pluripotent stem cells, or iPS cells, that are safe enough to use in…

    2–4 minutes
  • Health

    GlaxoSmithKline and Harvard Stem Cell Institute announce major collaboration agreement

    GlaxoSmithKline (GSK) and the Harvard Stem Cell Institute (HSCI) today announced that they have entered into a five-year, $25 million-plus collaborative agreement to build a unique alliance in stem cell…

    3–4 minutes